ICAAC 2015: Cempra CEO Sees Solithromycin Potential Beyond Infectious Diseases

Cempra Inc. president and CEO Prabha Fernandes sees the company's lead drug candidate solithromycin as a pipeline-in-a-pill with potential beyond infectious diseases and she's willing to follow all plausible leads given the macrolide antibiotic's immunomodulatory effects.